Paxillin confers resistance to tyrosine kinase inhibitors in EGFR-mutant lung cancers via modulating BIM and Mcl-1 protein stability.

Wu DW, Chen CY, Chu CL, Lee H
Oncogene. 2015 Apr 27. doi: 10.1038/onc.2015.120. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.